Status:
COMPLETED
Study : LEVOBUPIVACAINE Versus Placebo
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Pain
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
The locoregional anaesthesia is increasingly important in surgical practice, often allowing to simplify per- and post-operative analgesia. caesarian occurs in 20 % of delivery leading to a longer hosp...
Detailed Description
The study will be done at the department of Obstétric and gynecology, in the CHU of Saint-Etienne. It will include all patients requiring a caesarean without any contraindication. All the patients re...
Eligibility Criteria
Inclusion
- age \> 18 years
- all patients requiring a non-urgent caesarian done according to the Misgav-Ladach technique
Exclusion
- Patients requiring very urgent caesarian
- allergic to levobupivacaïne
- with previous history of alcoholism or drug addiction
- with severe hypotension or an ischemic cardiopathy badly compensated or thyrotoxicoses
- treated with first generation of IMAO (monoamine oxidase inhibitor) or with anti-arrhytmia drugs with anesthesic activity
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00621907
Start Date
March 1 2008
End Date
May 1 2009
Last Update
September 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Saint-Etienne, France, 42055